Desert King
  • Nosotros
  • Materias Primas
    • Administración de Materias Primas: Quillaja
    • Administración de Materias Primas: Yucca
    • Administración de Materias Primas: Jojoba
  • Líneas de Negocio
    • Farmacéutica
    • Nutrición y Salud Animal
    • Alimentación y Bebidas
    • Cuidado Personal y Cosmética
    • Agricultura
    • Medio ambiente y minería
  • Calidad
  • Noticias
  • Canal de Denuncias
  • Contacto
  • Inglés
  • Español
La Opción Natural La Opción Natural La Opción Natural La Opción Natural
  • Nosotros
  • Materias Primas
    • Administración de Materias Primas: Quillaja
    • Administración de Materias Primas: Yucca
    • Administración de Materias Primas: Jojoba
  • Líneas de Negocio
    • Farmacéutica
    • Nutrición y Salud Animal
    • Alimentación y Bebidas
    • Cuidado Personal y Cosmética
    • Agricultura
    • Medio ambiente y minería
  • Calidad
  • Noticias
  • Canal de Denuncias
  • Contacto
  • Inglés
  • Español

Archives

Alsayeqh, A.F., et al. Saponins and their role as vaccine adjuvant against coccidiosis in poultry.
0
By Desert King
In Texto Cientifico
Posted 7 julio, 2025

Alsayeqh, A.F., et al. Saponins and their role as vaccine adjuvant against coccidiosis in poultry.

Alsayeqh, A.F., et al. Saponins and their role as vaccine adjuvant against coccidiosis in poultry. Kafkas Univ Vet Fak Derg, 2025 June 13, 31 (3): 351-359.  This paper explores the potential of [...]

READ MORE
Áñez, G., et al. Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19).
0
By Desert King
In Texto Cientifico
Posted 7 julio, 2025

Áñez, G., et al. Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19).

Áñez, G., et al. Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19). Vaccine, 2025 Jun 5, [...]

READ MORE
Zhaoyun, L., et al. Enhancing antitumor immunity via ROS-ERS and pyroptosis-induced immunogenic cell death in multiple myeloma.
0
By Desert King
In Texto Cientifico
Posted 7 julio, 2025

Zhaoyun, L., et al. Enhancing antitumor immunity via ROS-ERS and pyroptosis-induced immunogenic cell death in multiple myeloma.

Zhaoyun, L., et al. Enhancing antitumor immunity via ROS-ERS and pyroptosis-induced immunogenic cell death in multiple myeloma. J Immunother Cancer, 2025 Jun 4, 13(6):e011717. PMID: 40473272 The [...]

READ MORE
Eygeris, Y., et al. Exploring the potential of saponins as adjuvants in lipid-nanoparticle-based mRNA vaccines.
0
By Desert King
In Texto Cientifico
Posted 7 julio, 2025

Eygeris, Y., et al. Exploring the potential of saponins as adjuvants in lipid-nanoparticle-based mRNA vaccines.

Eygeris, Y., et al. Exploring the potential of saponins as adjuvants in lipid-nanoparticle-based mRNA vaccines. Mol Ther Methods Clin Dev, 2025 May 21, 33(2):101495. PMID: 40525124 This study [...]

READ MORE
Rodrigues, K.A., et al. Vaccines combining slow release and follicle targeting of antigens increase germinal center B cell diversity and clonal expansion.
0
By Desert King
In Texto Cientifico
Posted 7 julio, 2025

Rodrigues, K.A., et al. Vaccines combining slow release and follicle targeting of antigens increase germinal center B cell diversity and clonal expansion.

Rodrigues, K.A., et al. Vaccines combining slow release and follicle targeting of antigens increase germinal center B cell diversity and clonal expansion. Sci Transl Med, 2025 Jun 18, [...]

READ MORE
Taquet, M., et al. Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections.
0
By Desert King
In Texto Cientifico
Posted 7 julio, 2025

Taquet, M., et al. Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections.

Taquet, M., et al. Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections. NPJ Vaccines, 2025 Jun 25, 10(1):130. PMID: 40562756 The [...]

READ MORE

DESERT KING INTERNATIONAL
745 Main Street-
Chula Vista, CA, USA, 91911
+1 619 429 5222
info@desertking.com

DESERT KING CHILE
Avenida Industrial 1970
Quilpué, Chile, 2420505
+56 32 292 5020
info@desertking.cl

DESERT KING MEXICO
Camino Vecinal 11500-A
Tijuana B.C., México, 22664
+52 664 636 11 24
info@desertkingmexico.com

© 2025 Desert King. All Right Reserved

Start typing and press Enter to search